Skip to main content

Your search for “Oncology” returned 285 results

Genetic Testing Cost Effective for Newly Diagnosed GIST

September 28, 2020

UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.

Leukemia in Remission for First Patient to Undergo CAR T-Cell Immunotherapy in San Diego

August 4, 2016

Robert Legaspi was 9 years old when he was first diagnosed with acute lymphoblastic leukemia (ALL). This year, at age 27, his leukemia returned for the fourth time. This time was different, though — on May 20, 2016, Legaspi became the first patient in San Diego to receive a new…

UC San Diego Health and Eisenhower Health Affiliation Expands Cancer Services in Coachella Valley

January 11, 2018

UC San Diego Health and Eisenhower Health signed a five-year affiliation agreement to expand cancer services for residents of Coachella Valley. Starting in January 2018, as a member of the UC San Diego Health Cancer Network, patients of Eisenhower Health will have enhanced access to world-class cancer care, both at…

Patients with Gastrointestinal Tumors at Higher Risk of Other Cancers

May 1, 2015

Researchers at UC San Diego School of Medicine conducted the first population-based study that characterizes the association and temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers. The results, published by Cancer on April 30, indicate that one in 5.8 patients with GIST will develop additional malignancies before and…

Stand Up To Cancer Grant Funds UC San Diego Health Research in Pancreatic Cancer

November 20, 2018

A team of University of California San Diego School of Medicine researchers have been awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer.

Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers

July 30, 2020

Researchers at UC San Diego School of Medicine and Moores Cancer Center report that an investigational drug candidate called tipifarnib showed promise in treating key recurring mutation in head and neck cancers.

UC San Diego Health Physicians Named ‘Top Docs’ in San Diego County

October 10, 2022

More than 100 UC San Diego Health physicians have been named “Top Docs” in the 2022 San Diego Magazine “Physicians of Exceptional Excellence” survey.

Senator Toni Atkins Visits Hospital to Recognize Plans for New Hillcrest Campus

July 23, 2021

Senate President Pro Tempore Toni Atkins visited UC San Diego Medical Center today to recognize a $30 million allocation in the 2021-2022 California state budget that will support the redevelopment of the new Hillcrest hospital.

Tethering of Shattered Chromosomal Fragments Paves Way for New Cancer Therapies

June 15, 2023

UC San Diego scientists discover shattered chromosomal fragments are tethered together during cell division before being rearranged; destroying the tether may help prevent cancerous mutations

$25 Million Gift to UC San Diego Establishes the McGrath Outpatient Pavilion

December 5, 2023

The San Diego-based McGrath Family Foundation has pledged $25 million to support the new outpatient pavilion at UC San Diego Health – Hillcrest Medical Campus, slated to open in 2025. In recognition of the gift, the facility will be named the McGrath Family Foundation Outpatient Pavilion.

Category navigation with Social links